Phase 2 tested 1 mg, 4 mg, 8 mg, and 12 mg
Semaglutide dosing protocol The standard semaglutide titration for weight management follows a well-established 16-20 week escalation schedule: Weeks 1-4: 0.25 mg once weekly Weeks 5-8: 0.50 mg once weekly Weeks 9-12: 1.0 mg once weekly Weeks 13-16: 1.7 mg once weekly Week 17 onward: 2.4 mg once weekly (maintenance dose) This graduated approach serves two purposes
Patients who received the 8 mg weekly dose lost 17.3% and those in the 12 mg group lost 17.5% of body weight, compared to only 1.6% in the placebo group
Stay at the forefront of discovery, explore Prime Lab Peptides research-grade Retatrutide today, and support the next wave of scientific innovation
The GIPR missense variant, rs1800437, has been associated with a large number of traits in the public domain, including BMI and body mass phenotypes, T2D, blood glucose and a number of metabolic or haematologic traits including blood pressure, reticulocyte and/or erythrocyte volume and urinary calculus (Supplementary Table 18)
Causes can include polyps, fibroids, endometrial issues, or pregnancy